vs
DXP ENTERPRISES INC（DXPE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是DXP ENTERPRISES INC的1.2倍（$622.0M vs $527.4M），Royalty Pharma plc净利率更高（34.4% vs 4.3%，领先30.1%），DXP ENTERPRISES INC同比增速更快（12.0% vs 4.8%），过去两年DXP ENTERPRISES INC的营收复合增速更高（13.1% vs 4.6%）
DXP Enterprises Inc.是一家领先的工业分销企业，提供维护、维修、运营（MRO）用品、流体处理设备、泵系统及相关技术服务，主要服务制造业、能源、矿业、建筑等领域客户，核心市场覆盖北美地区。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DXPE vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$527.4M
营收增速更快
DXPE
高出7.2%
4.8%
净利率更高
RPRX
高出30.1%
4.3%
两年增速更快
DXPE
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $527.4M | $622.0M |
| 净利润 | $22.8M | $214.2M |
| 毛利率 | 31.6% | — |
| 营业利润率 | 8.8% | 62.4% |
| 净利率 | 4.3% | 34.4% |
| 营收同比 | 12.0% | 4.8% |
| 净利润同比 | 6.9% | 2.9% |
| 每股收益（稀释后） | $1.38 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXPERPRX
| Q4 25 | $527.4M | $622.0M | ||
| Q3 25 | $513.7M | $609.3M | ||
| Q2 25 | $498.7M | $578.7M | ||
| Q1 25 | $476.6M | $568.2M | ||
| Q4 24 | $470.9M | $593.6M | ||
| Q3 24 | $472.9M | $564.7M | ||
| Q2 24 | $445.6M | $537.3M | ||
| Q1 24 | $412.6M | $568.0M |
净利润DXPERPRX
| Q4 25 | $22.8M | $214.2M | ||
| Q3 25 | $21.6M | $288.2M | ||
| Q2 25 | $23.6M | $30.2M | ||
| Q1 25 | $20.6M | $238.3M | ||
| Q4 24 | $21.4M | $208.2M | ||
| Q3 24 | $21.1M | $544.0M | ||
| Q2 24 | $16.7M | $102.0M | ||
| Q1 24 | $11.3M | $4.8M |
毛利率DXPERPRX
| Q4 25 | 31.6% | — | ||
| Q3 25 | 31.4% | — | ||
| Q2 25 | 31.6% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.9% | — | ||
| Q2 24 | 30.9% | — | ||
| Q1 24 | 30.0% | — |
营业利润率DXPERPRX
| Q4 25 | 8.8% | 62.4% | ||
| Q3 25 | 8.5% | 70.1% | ||
| Q2 25 | 9.2% | 36.3% | ||
| Q1 25 | 8.5% | 94.0% | ||
| Q4 24 | 8.3% | 60.9% | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | 8.4% | 50.2% | ||
| Q1 24 | 7.1% | -13.0% |
净利率DXPERPRX
| Q4 25 | 4.3% | 34.4% | ||
| Q3 25 | 4.2% | 47.3% | ||
| Q2 25 | 4.7% | 5.2% | ||
| Q1 25 | 4.3% | 41.9% | ||
| Q4 24 | 4.5% | 35.1% | ||
| Q3 24 | 4.5% | 96.3% | ||
| Q2 24 | 3.7% | 19.0% | ||
| Q1 24 | 2.7% | 0.8% |
每股收益（稀释后）DXPERPRX
| Q4 25 | $1.38 | $0.49 | ||
| Q3 25 | $1.31 | $0.67 | ||
| Q2 25 | $1.43 | $0.07 | ||
| Q1 25 | $1.25 | $0.55 | ||
| Q4 24 | $1.28 | $0.46 | ||
| Q3 24 | $1.27 | $1.21 | ||
| Q2 24 | $1.00 | $0.23 | ||
| Q1 24 | $0.67 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $303.8M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $498.4M | $9.7B |
| 总资产 | $1.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DXPERPRX
| Q4 25 | $303.8M | $618.7M | ||
| Q3 25 | $123.8M | $938.9M | ||
| Q2 25 | $112.9M | $631.9M | ||
| Q1 25 | $114.3M | $1.1B | ||
| Q4 24 | $148.3M | $929.0M | ||
| Q3 24 | $35.0M | $950.1M | ||
| Q2 24 | $49.9M | $1.8B | ||
| Q1 24 | $139.7M | $843.0M |
总债务DXPERPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益DXPERPRX
| Q4 25 | $498.4M | $9.7B | ||
| Q3 25 | $488.3M | $9.6B | ||
| Q2 25 | $468.1M | $9.5B | ||
| Q1 25 | $444.7M | $9.8B | ||
| Q4 24 | $422.8M | $10.3B | ||
| Q3 24 | $402.4M | $10.3B | ||
| Q2 24 | $384.7M | $9.8B | ||
| Q1 24 | $375.5M | $9.9B |
总资产DXPERPRX
| Q4 25 | $1.7B | $19.6B | ||
| Q3 25 | $1.4B | $19.3B | ||
| Q2 25 | $1.4B | $18.3B | ||
| Q1 25 | $1.4B | $17.6B | ||
| Q4 24 | $1.3B | $18.2B | ||
| Q3 24 | $1.2B | $18.0B | ||
| Q2 24 | $1.2B | $17.7B | ||
| Q1 24 | $1.2B | $16.1B |
负债/权益比DXPERPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $34.5M | — |
| 自由现金流率自由现金流/营收 | 6.5% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 1.65× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $54.0M | — |
8季度趋势，按日历期对齐
经营现金流DXPERPRX
| Q4 25 | $37.8M | $827.1M | ||
| Q3 25 | $34.9M | $702.6M | ||
| Q2 25 | $18.6M | $364.0M | ||
| Q1 25 | $3.0M | $596.1M | ||
| Q4 24 | $32.1M | $742.5M | ||
| Q3 24 | $28.3M | $703.6M | ||
| Q2 24 | $14.7M | $658.2M | ||
| Q1 24 | $27.0M | $664.6M |
自由现金流DXPERPRX
| Q4 25 | $34.5M | — | ||
| Q3 25 | $28.1M | — | ||
| Q2 25 | $8.3M | — | ||
| Q1 25 | $-16.9M | — | ||
| Q4 24 | $22.7M | — | ||
| Q3 24 | $24.4M | — | ||
| Q2 24 | $5.9M | — | ||
| Q1 24 | $24.1M | — |
自由现金流率DXPERPRX
| Q4 25 | 6.5% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 5.8% | — |
资本支出强度DXPERPRX
| Q4 25 | 0.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 0.7% | — |
现金转化率DXPERPRX
| Q4 25 | 1.65× | 3.86× | ||
| Q3 25 | 1.61× | 2.44× | ||
| Q2 25 | 0.79× | 12.06× | ||
| Q1 25 | 0.14× | 2.50× | ||
| Q4 24 | 1.50× | 3.57× | ||
| Q3 24 | 1.34× | 1.29× | ||
| Q2 24 | 0.88× | 6.45× | ||
| Q1 24 | 2.38× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXPE
| Service Centers | $356.2M | 68% |
| Innovative Pumping Solutions | $110.0M | 21% |
| Supply Chain Services | $61.2M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
